-
1
المؤلفون: Katja K.H. Aben, Carin A. Uyl-de Groot, Joan van den Bosch, Inge M. van Oort, Saskia van der Meer, Andries M. Bergman, Jules L.L.M. Coenen, Winald R. Gerritsen, Diederik M. Somford, Hans M. Westgeest, Jules Lavalaye, Alphons C.M. van den Bergh, Mathijs P. Hendriks, Maarten J. van der Doelen, Malou C.P. Kuppen, Filiz Celik, Marco B. Polee, Alphonsus J. M. van den Eertwegh
المساهمون: Medical oncology, CCA - Cancer Treatment and quality of life, CCA - Imaging and biomarkers, Health Technology Assessment (HTA), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Kuppen, M C, Westgeest, H M, van der Doelen, M J, van den Eertwegh, A J, Coenen, J L, Aben, K K, van den Bergh, A C, Bergman, A M, den Bosch, J V, Celik, F, Hendriks, M P, Lavalaye, J, der Meer, S V, Polee, M B, Somford, D M, van Oort, I M, Uyl-de Groot, C A & Gerritsen, W R 2020, ' Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer ', Future Oncology, vol. 16, no. 19, pp. 1371-1384 . https://doi.org/10.2217/fon-2020-0039
Future Oncology, 16(19), 1371-1384. Future Medicine Ltd.
Future Oncology, 16, 19, pp. 1371-1384
Future oncology, 16(19), 1371-1384. FUTURE MEDICINE LTD
Future Oncology, 16, 1371-1384مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Treatment completion, Databases, Factual, radium-223, THERAPY, RECOMMENDATIONS, Prostate cancer, DOUBLE-BLIND, 0302 clinical medicine, Aged, 80 and over, BONE METASTASES, Real world outcomes, CYCLES, General Medicine, sequencing, Middle Aged, real-world outcomes, Survival Rate, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], 030220 oncology & carcinogenesis, TRIAL, medicine.drug, Radium, Radium-223, medicine.medical_specialty, PHASE-3, Antineoplastic Agents, Bone Neoplasms, Castration resistant, survival, Drug Administration Schedule, Double blind, EVENTS, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], medicine, Humans, Radium-223 Dichloride, Aged, Retrospective Studies, Radioisotopes, Window of opportunity, business.industry, medicine.disease, EFFICACY, skeletal-related events, 030104 developmental biology, metastatic castration-resistant prostate cancer, EXPERIENCE, business
وصف الملف: application/pdf
-
2
المؤلفون: Haiko J. Bloemendal, Niven Mehra, Marco B. Polee, Joan van den Bosch, Alphonsus J. M. van den Eertwegh, Carin A. Uyl-de Groot, Daan ten Bokkel Huinink, H. P. (Pieter) van den Berg, Andre M. Bergman, Inge M. van Oort, Malou C.P. Kuppen, Addy C. M. van de Luijtgaarden, Laurent M.C.L. Fossion, Mathijs P. Hendriks, Juleon L.L.M. Coenen, Winald R. Gerritsen, Hans M. Westgeest, A.C.M. van den Bergh, Ronald de Wit, N.I. Weijl
المساهمون: Health Technology Assessment (HTA), Medical Oncology, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Medical oncology, CCA - Cancer Treatment and quality of life
المصدر: Clinical Genitourinary Cancer, 17, 5, pp. e946-e956
Clinical Genitourinary Cancer, 17(5), E946-E956. Elsevier
Clinical genitourinary cancer, 17(5), E946-E956. CIG MEDIA GROUP, LP
Westgeest, H M, Kuppen, M C P, van den Eertwegh, A J M, de Wit, R, Coenen, J L L M, van den Berg, H P, Mehra, N, van Oort, I M, Fossion, L M C L, Hendriks, M P, Bloemendal, H J, van de Luijtgaarden, A C M, ten Bokkel Huinink, D, van den Bergh, A C M, van den Bosch, J, Polee, M B, Weijl, N, Bergman, A M, Uyl-de Groot, C A & Gerritsen, W R 2019, ' Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands ', Clinical Genitourinary Cancer, vol. 17, no. 5, pp. e946-e956 . https://doi.org/10.1016/j.clgc.2019.05.018
Clinical Genitourinary Cancer, 17(5), e946-e956. Elsevier
Clinical Genitourinary Cancer, 17, e946-e956مصطلحات موضوعية: Male, Oncology, medicine.medical_treatment, 030232 urology & nephrology, PLUS PREDNISONE, Androgen deprivation therapy, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Medicine, Neoplasm Metastasis, Netherlands, DOCETAXEL, Clinical Trials as Topic, education.field_of_study, CYCLES, Abiraterone acetate, Standard of Care, MEN, Middle Aged, CHEMOTHERAPY, Prognosis, OPEN-LABEL, ABIRATERONE ACETATE, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Docetaxel, Cabazitaxel, SAFETY, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], 030220 oncology & carcinogenesis, POSTDOCETAXEL, Taxoids, medicine.drug, Registry, medicine.medical_specialty, Urology, Population, INCREASED SURVIVAL, Antineoplastic Agents, 03 medical and health sciences, Trial eligibility, SDG 3 - Good Health and Well-being, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], Humans, Real-world outcomes, education, Aged, Retrospective Studies, Chemotherapy, L-Lactate Dehydrogenase, business.industry, Prostate-Specific Antigen, medicine.disease, Survival Analysis, Trial population, Clinical trial, chemistry, business
وصف الملف: application/pdf
-
3
المؤلفون: Diederik M. Somford, Reindert J.A. van Moorselaar, Carin A. Uyl-de Groot, Ronald de Wit, Laurent M.C.L. Fossion, Niven Mehra, Hans M. Westgeest, Addy C. M. van de Luijtgaarden, Juleon L.L.M. Coenen, N.I. Weijl, Maud M. Geenen, Winald R. Gerritsen, Agnes J. van de Wouw, A.C.M. van den Bergh, Mathijs P. Hendriks, Marco B. Polee, Alphonsus J. M. van den Eertwegh, Andre M. Bergman, Malou C.P. Kuppen, Inge M. van Oort, Daan ten Bokkel Huinink
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Health Technology Assessment (HTA), Medical oncology, Urology, CCA - Cancer Treatment and quality of life, Internal medicine
المصدر: European urology oncology, 4(4), 618-627. De Tijdstroom/Elsevier
European Urology Oncology, 4, 618-627
European urology oncology, 4, 618-627. Elsevier
Kuppen, M C P, Westgeest, H M, van den Eertwegh, A J M, van Moorselaar, R J A, van Oort, I M, Coenen, J L L M, van den Bergh, A C M F, Mehra, N, Somford, D M, Bergman, A M, Ten Bokkel Huinink, D, Fossion, L, Geenen, M M, Hendriks, M P, van de Luijtgaarden, A C M, Polee, M B, Weijl, N I, van de Wouw, A J, de Wit, R, Uyl-de Groot, C A & Gerritsen, W R 2021, ' Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer : Results from the Dutch Castration-resistant Prostate Cancer Registry ', European Urology Oncology, vol. 4, no. 4, pp. 618-627 . https://doi.org/10.1016/j.euo.2019.09.005
European Urology Oncology, 4, 4, pp. 618-627
European Urology Oncology, 4(4), 618-627. Elsevier BVمصطلحات موضوعية: Oncology, Male, ANTITUMOR-ACTIVITY, 030232 urology & nephrology, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Prednisone, Medicine, Sequencing, Registries, Castration-resistant prostate cancer, DOCETAXEL, Abiraterone acetate, TIME, Prostatic Neoplasms, Castration-Resistant, TRIALS, Docetaxel, Pharmaceutical Preparations, Cabazitaxel, 030220 oncology & carcinogenesis, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Androgens, Cross resistance, medicine.drug, medicine.medical_specialty, CLINICAL-OUTCOMES, ENZALUTAMIDE, Urology, INCREASED SURVIVAL, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Antigen, SDG 3 - Good Health and Well-being, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], Enzalutamide, Humans, Radiology, Nuclear Medicine and imaging, Real-world outcomes, Retrospective Studies, Androgen-receptor targeting agents, business.industry, Androgen Antagonists, medicine.disease, Androgen receptor, chemistry, Surgery, business
وصف الملف: application/pdf
-
4
المؤلفون: Igor Cordia, Joan van den Bosch, Hans M. Westgeest, Aad I. de Vos, Lidwine W. Tick, Ronald de Wit, Marco B. Polee, Maud M. Geenen, Alphonsus J. M. van den Eertwegh, Frank P. J. Peters, Mathijs P. Hendriks, Roan Spermon, Michiel O. Boerma, Carin A. Uyl-de Groot, Winald R. Gerritsen, Harrie P. Beerlage, Agnes J. van de Wouw, Alphonsus C. M. van den Bergh, Jules L.L.M. Coenen, Monique M.E.M. Bos, Reindert J.A. van Moorselaar, Pieter van den Berg, Haiko J. Bloemendal
المساهمون: CCA - Cancer Treatment and Quality of Life, CCA - Cancer Treatment and quality of life, Urology, Medical oncology, Health Technology Assessment (HTA), Medical Oncology
المصدر: European Urology Focus, 4(5), 694. Elsevier BV
European Urology Focus, 4, 694-701
European urology focus, 4(5), 694-701. Elsevier BV
European Urology Focus, 4(5), 694-701. Elsevier BV
European Urology, 4(5), 694-701. Elsevier
European Urology Focus, 4, 5, pp. 694-701
Westgeest, H M, Uyl-de Groot, C A, van Moorselaar, R J A, de Wit, R, van den Bergh, A C M, Coenen, J L L M, Beerlage, H P, Hendriks, M P, Bos, M M E M, van den Berg, P, van de Wouw, A J, Spermon, R, Boerma, M O, Geenen, M M, Tick, L W, Polee, M B, Bloemendal, H J, Cordia, I, Peters, F P J, de Vos, A I, van den Bosch, J, van den Eertwegh, A J M & Gerritsen, W R 2018, ' Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry ', European Urology Focus, vol. 4, no. 5, pp. 694-701 . https://doi.org/10.1016/j.euf.2016.09.008مصطلحات موضوعية: Male, Registry of outcomes, 030232 urology & nephrology, Docetaxel, Prostate cancer, 0302 clinical medicine, Medicine, Registries, Neoplasm Metastasis, Netherlands, Castration-resistant prostate cancer, Aged, 80 and over, education.field_of_study, Population based, Standard treatment, Incidence, Middle Aged, Tubulin Modulators, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Outcomes research, 030220 oncology & carcinogenesis, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], medicine.drug, medicine.medical_specialty, Registry, Urology, Population, Disease-Free Survival, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, Pragmatic Clinical Trials as Topic, Journal Article, Humans, Real-world outcomes, education, Aged, Retrospective Studies, business.industry, Proportional hazards model, Prostatic Neoplasms, medicine.disease, Clinical trial, Treatment, Trial population, Physical therapy, Observational study, business
وصف الملف: image/pdf; application/pdf
PDF full text from Publisher 
Full Text via ClinicalKey